glp 1 in non diabetic GLP-1 Meds Reduce Risk of Various Ocular Complications Non-diabetic Patients Mapping the effectiveness and risks
Description
Jager J, Gremeaux T, Cormont M, Le Marchand-Brustel Y, Tanti JF
Medicaid coverage for GLP-1s, both for Type 2 diabetes and obesity, varies widely across the United States
A clinical trial in 2015 linked an undisclosed GLP-1 to significant improvements in OSA severity, while a 2016 clinical trial found that weight loss resulting from liraglutide was significantly associated with a reduction in the apnea-hypopnea index (AHI)
D., Stierman, B., & Ogden, C
He felt fuller after meals and grabbed fewer post-dinner snacks
Your doctor will discuss the expected timeline during your consultation
